
Edgewise Therapeutics appoints Michael Carruthers to be CFO
BOULDER -- Edgewise Therapeutics, a clinical-stage biopharmaceutical company developing small molecule therapies for musculoskeletal diseases, today announced the appointment of R. Michael... Read More
Monday October 19, 2020 0 comments

OnKure adds 3 key members to exec team
BOULDER -- OnKure, Inc . announced the appointment of three key members to its management team. They are: James Winkler , VP of discovery and translational biology; R. Michael Carruthers ,... Read More
Thursday September 26, 2019 0 comments